Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis

British Journal of Cancer

Volumn 88, Issue 9, 2003, Pages 1424-1431

  Li, C ^a   Gardy, R ^a   Seon, B K ^b   Duff, S E ^c   Abdalla, S ^d   Renehan, A ^c   O'Dwyer, S T ^c   Haboubi, N ^e   Kumar, S ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c CHRISTIE HOSPITAL   (United Kingdom)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e TRAFFORD GENERAL HOSPITAL   (United Kingdom)

Author keywords

Angiogenesis; Microvessel density (MVD); Soluble CD105; TGF

Indexed keywords

ANGIOGENESIS INHIBITOR; CANCER ANTIBODY; CD105 ANTIBODY; CD34 ANTIGEN; ENDOGLIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3; TUMOR ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOGENESIS; ANTIBODY BLOOD LEVEL; ANTIGEN EXPRESSION; ARTICLE; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MALE; METASTASIS; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; TUMOR GROWTH; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; COLONIC NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MICROCIRCULATION; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RECEPTORS, CELL SURFACE; RECTAL NEOPLASMS; SURVIVAL ANALYSIS; TIME FACTORS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0038146840     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600874     Document Type: Article

References (33)

1. Abdalla S, Behzad F, Bsharah S, Kumar S, Amini S, O'Dwyer S, Haboubi N (1999) Prognostic relevance of microvessel density in colorectal tumours. Oncol Rep 6: 839-842
2. Akagi K, Ikeda Y, Sumiyoshi Y, Kimura Y, Kinoshita J, Miyazaki M, Abe T (2002) Estimation of angiogenesis with anti-CD105 immunostaining in the process of colorectal cancer development. Surgery 131(Suppl 1): S109-S113
3. Akslen L, Livolsi V (2000) Increased angiogenesis in papillary thyroid carcinoma but lack of prognostic importance. Hum Pathol 31: 439-442
4. Bodey B, Bodey BJ, Siegel S, Kaiser H (1998) Over-expression of endoglin (CD105): a marker of breast carcinoma-induced neo-vascularization. Anticancer Res 18: 3621-3628
5. Brewer C, Setterdahl J, Li M, Johnston J, McAsey M (2000) Endoglin expression as a measure of microvessel density in cervical cancer. Obstet Gynecol 96: 224-228
6. Burrows F, Derbyshire E, Tazzari P, Amlot P, Gazdar A, King S, Letarte M, Vitetta E, Thorpe P (1995) Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy. Clin Cancer Res 1: 1623-1634
7. Chung Y, Maeda K, Sowa M (1996) Prognostic value of angiogenesis in gastro-intestinal tumours. Eur J Cancer 32A: 2501-2505
8. de Jong J, van Diest P, Baak J (2000) Hot spot microvessel density and the mitotic activity index are strong additional prognostic indicators in invasive breast cancer. Histopathology 36: 306-312
9. Folkman J (1996) Tumor angiogenesis and tissue factor. Nat Med 2: 167-168
10. Fonsatti E, Vecchio L, Altomonte M, Sigalotti L, Nicotra M, Coral S, Natali P, Maio M (2001) Endoglin: an accessory component of the TGF-beta-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies. J Cell Physiol 188: 1-7
11. Ghellal A, Li C, Hayes M, Byrne G, Bundred N, Kumar S (2000) Prognostic significance of TGF beta 1 and TGF beta 3 in human breast carcinoma. Anticancer Res 20: 4413-4418
12. Gohongi T, Fukumura D, Boucher Y, Yun C, Soff G, Compton C, Todoroki T, Jain R (1999) Tumor-host interactions in the gallbladder suppress distal angiogenesis and tumor growth: involvement of transforming growth factor beta1. Nat Med 5: 1203-1208
13. Gold L, Jussila T, Fusenig N, Stenback F (2000) TGF-beta isoforms are differentially expressed in increasing malignant grades of HaCaT keratinocytes, suggesting separate roles in skin carcinogenesis. J Pathol 190: 579-588
14. Grainger D, Mosedale D, Metcalfe J, Weissberg P, Kemp P (1995) Active and acid-activatable TGF-beta in human sera, platelets and plasma. Clin Chim Acta 235: 11-31
15. Kloen P, Gebhardt M, Perez-Atayde A, Rosenberg A, Springfield D, Gold L, Mankin H (1997) Expression of transforming growth factor-beta (TGF-beta) isoforms in osteosarcomas: TGF-beta3 is related to disease progression. Cancer 80: 2230-2239
16. Krupinski J, Kaluza J, Kumar P, Kumar S, Wang J (1994) Role of angiogenesis in patients with cerebral ischemic stroke. Stroke 25: 1794-1798
17. Kumar P, Wang J, Bernabeu C (1996) CD105 and angiogenesis. J Pathol 178: 363-366
18. Kumar S, Ghellal A, Li C, Byrne G, Haboubi N, Wang J, Bundred N (1999) Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis. Cancer Res 59: 856-861
19. Li C, Bethell H, Wilson P, Bhatnagar D, Walker M, Kumar S (2000a) The significance of CD105, TGFbeta and CD105/TGFbeta complexes in coronary artery disease. Atherosclerosis 152: 249-256
20. Li C, Guo B, Bernabeu C, Kumar S (2001) Angiogenesis in breast cancer: the role of transforming growth factor beta and CD105. Microsc Res Tech 52: 437-449
21. Li C, Guo B, Wilson P, Stewart A, Byrne G, Bundred N, Kumar S (2000b) Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer. Int J Cancer 89: 122-126
22. Li C, Wang J, Wilson P, Kumar P, Levine E, Hunter R, Kumar S (1998) Role of transforming growth factor beta3 in lymphatic metastasis in breast cancer. Int J Cancer 79: 455-459
23. Miller D, Graulich W, Karges B, Stahl S, Ernst M, Ramaswamy A, Sedlacek H, Muller R, Adamkiewicz J (1999) Elevated expression of endoglin, a component of the TGF-beta-receptor complex, correlates with proliferation of tumor endothelial cells. Int J Cancer 81: 568-572
24. Pignataro L, Carboni N, Midolo V, Bertolini F, Buffa R, Cesana B, Neri A, Viale G, Pruneri G (2001) Clinical relevance of microvessel density in laryngeal squamous cell carcinomas. Int J Cancer 92: 666-670
25. Rich JN, Borton AJ, Wang XF (2001) Transforming growth factor-β signaling in cancer. Microsc Res Tech 52: 363-373
26. Sabo E, Boltenko A, Sova Y, Stein A, Kleinhaus S, Resnick M (2001) Microscopic analysis and significance of vascular architectural complexity in renal cell carcinoma. Clin Cancer Res 7: 533-537
27. Seon B, Matsuno F, Haruta Y, Kondo M, Barcos M (1997) Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin. Clin Cancer Res 3: 1031-1044
28. Srivastava A, Laidler P, Davies R, Horgan K, Hughes L (1988) The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. A quantitative histologic study. Am J Pathol 133: 419-423
29. Takahashi N, Kawanishi-Tabata R, Haba A, Tabata M, Haruta Y, Tsai H, Seon B (2001) Association of serum endoglin with metastasis in patients with colorectal, breast, and other solid tumors, and suppressive effect of chemotherapy on the serum endoglin. Clin Cancer Res 7: 524-532
30. Thompson W, Shiach K, Fraser R, McIntosh L, Simpson J (1987) Tumours acquire their vasculature by vessel incorporation, not vessel ingrowth. J Pathol 151: 323-332
31. Wang J, Kumar S, Pye D, Haboubi N, al-Nakib L (1994) Breast carcinoma: comparative study of tumor vasculature using two endothelial cell markers. J Natl Cancer Inst 86: 386-388
32. Weidner N (1999) Tumour vascularity and proliferation: clear evidence of a close relationship. J Pathol 189: 297-299
33. Weidner N (2000) Angiogenesis as a predictor of clinical outcome in cancer patients. Hum Pathol 31: 403-405